Skip to main content

Medicines Shouldn't Be a Luxury

Medicines Shouldn't Be a Luxury

On March 27th, 2017 The international medical humanitarian organisation Médecins Sans Frontières (MSF) filed a patent challenge on the Hepatitis C drug Sofosbuvir with the European Patent Office (EPO) in an effort to increase access to affordable Hepatitis C treatment.  MSF has joined Médecins du Monde (MdM) and other civil society organisations from 17 countries in simultaneously filing patent challenges on the pharmaceutical corporation Gilead’s monopoly on Sofosbuvir, in a bid to remove the barriers that prevent millions of people receiving treatment.
 
You can read the full article by clicking here.
 
 
Share

Steady Progress Towards SDG#4

Aug 02, 2020

  The Global Partnership for Education’s (GPE’s) latest annual report is showing that great strides are being made to bring quality education to the world’s most marginalized children.  ... Read more

World Refugee Day - It's Her Turn

Jun 17, 2020

June 20th marks World Refugee Day. For millions of women and girls among the world’s ever-growing refugee population, education remains an aspiration, not a reality.  In Africa, COVID-19 is... Read more

Twitter Icon RT : “Right now you're at the mercy of the whims of companies to pick which countries, for which price, at what time, at… https://t.co/rNO7IW9tOT 1 day 5 hours ago